Gerresheimer集团快讯第六期

Gerresheimer opens a representative office in India

格雷斯海姆在印度设立代表处

l  Gerresheimer steps up business operations in emerging markets

格雷斯海姆将其业务加快步入新兴市场的步伐

l  Local sales operations, customer services and technical services are being extended.

       当地销售经营，客服以及技术服务都在扩展。

l  Dynamic growth in the Indian pharma market

       在印度医药市场的强力增长

      Gerresheimer AG, one of the world’s leading suppliers to the pharma and healthcare industry, is still expanding its global operations. The establishment of a representative office in Mumbai/India reflects the company’s commitment to the strategy of profiting from the consistent growth in emerging markets.

       全球制药和保健行业领先供应商之一的格雷斯海姆集团有限公司，还在不断扩大其全球业务。在孟买/印度代表办事处的设立实现了该公司对于新兴市场持续成长获利策略的承诺。

      Gerresheimer intends to advance its very promising pharmaceutical primary packaging and drug delivery systems business in the growth market of India. In addition to sales operations, the company is also stepping up its local customer services and technical services.

      格雷斯海姆公司打算以其非常有前途的初级包装和药物输送系统业务在快速成长中的印度医药市场中增长。除了销售业务，公司还加强了当地的客户服务和技术服务。

      “Our strategic objective is to achieve above average growth in the emerging markets. We currently generate around ten percent of our revenues in these dynamically growing markets and we aim to double this figure over the next three years. Opening our representative office in India is an important step towards achieving this objective,” said Uwe Röhrhoff, CEO of Gerresheimer AG.

      “我们的战略目标是要实现以上的新兴市场的平均增长。目前，我们大约百分之十的收入都来自这些动态发展的市场，我们的目标实在未来三年将次数翻番。我们在印度设立代表处是朝着实现这一目标发展的重要一步，”格雷斯海姆集团公司股份公司首席执行官罗豪夫讲到。

      Alongside China, where Gerresheimer already has seven production facilities, the fast-growing Indian pharma market is continually gaining in significance. There is incessant growth of demand for medicines in India. One reason for this is the improvement of the Indian healthcare system, which gives people greater access to medications. International pharmaceutical groups are now also manufacturing more products in India for other regions. Leading market research institutes expect above average growth rates in emerging nation pharma markets over coming years.

      在中国，格雷斯海姆集团已经拥有七个生产设备工厂，快速增长的印度制药市场还在不断发展。目前印度不断对药品需求的增长的原因之一是印度医疗体系的改进，使得人们有更多的机会，更容易的获得医疗药物。国际制药集团目前也在印度为其他地区制造更多产品。领先的市场研究机构对上述新兴国家在未来几年医药市场的平均增长率有所期待。